13F filing recap · Q4 2024
What did Matrix Asset Advisors buy in Q4 2024?
Reported stock-position changes between this filing and the previous one.
Stock value
$915.66M
Positions
110
Estimated turnover
8.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Matrix Asset Advisors opened new positions in Dollar General, Humana, Docgo, Automatic Data Processing, Lockheed Martin, Aon, Broadcom, Amphenol, and Honeywell, while exiting Gartner entirely. The firm substantially added to Amgen, PepsiCo, Berkshire Hathaway, Bank of America, Accenture, Costco, Eaton, and Intuit. It trimmed UnitedHealth Group, Pfizer, Fiserv, Gilead Sciences, and CVS Health, and sharply reduced Becton Dickinson, the SPDR Gold Trust, and Paramount Global.